scispace - formally typeset
P

Paulus Kirchhof

Researcher at University of Birmingham

Publications -  659
Citations -  119822

Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.

Papers
More filters
Journal Article

Abstract 18782: Regional Action Potential Heterogeneity in the Murine Pitx2c Deficient Left Atrium

TL;DR: Compared regional action potential (AP) morphology in PITX2c+/- and wild type (WT) littermate mice, partial depletion in Pitx2c mRNA expression causes a uniform APD shortening throughout the LA and loss of regional changes in AP amplitude.
Journal ArticleDOI

Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both?

TL;DR: A systematic analysis of temporal trends ofAF ablation success rates in an unselected population undergoing a first AF ablation in clinical practice and the rates of repeat ablation appear to be comparable to other large cohorts.
Journal ArticleDOI

Repolarization indicates electrical instability in ventricular arrhythmia originating from papillary muscle

TL;DR: The parameter repolarization time in relation to cycle length (RT/CL) is found to differentiate self-limiting from degenerating arrhythmia with high specificity and sensitivity and may serve as a simple index to aid differentiation between self- Limiting and electrically instable arrhythmias with the propensity to degenerate to VF.
Journal ArticleDOI

Complex antithrombotic combinations: how to find the perfect blend?

TL;DR: The optimal combination of aspirin, platelet P2Y12 inhibitor and anticoagulant is still unknown, and a one-size-fits-all approach may never be possible, but five randomised controlled trials on this topic have taught us that discontinuation of aspirin significantly reduces the risk of major bleeding.